Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).
about
Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis.Treatment of older patients with acute myeloid leukemia (AML): revised Canadian consensus guidelines.Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis.Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.
P2860
Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Outcome of allogeneic stem cel ...... elderly patients (⩾60 years).
@en
Outcome of allogeneic stem cel ...... c syndrome in elderly patients
@nl
type
label
Outcome of allogeneic stem cel ...... elderly patients (⩾60 years).
@en
Outcome of allogeneic stem cel ...... c syndrome in elderly patients
@nl
prefLabel
Outcome of allogeneic stem cel ...... elderly patients (⩾60 years).
@en
Outcome of allogeneic stem cel ...... c syndrome in elderly patients
@nl
P2093
P2860
P356
P1476
Outcome of allogeneic stem cel ...... n elderly patients (⩾60 years)
@en
P2093
C Müller-Tidow
C Schliemann
M Stelljes
W E Berdel
P2860
P2888
P304
P356
10.1038/BMT.2016.156
P407
P577
2016-06-13T00:00:00Z